Photodynamic Therapy Market to grow at a CAGR of 8.22% from 2022 to 2027 | Early detection of cancer to boost the market growth - Technavio

NEW YORK, Aug. 4, 2023 /PRNewswire/ -- The photodynamic therapy market size to grow by USD 2,053.68 million from 2022 to 2027, progressing at a CAGR of 8.22% during the forecast period. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. Early detection of cancer is a key factor driving market growth. Lack of exercise and excessive tobacco and alcohol consumption can lead to many types of cancer, including lung, stomach, kidney, head and neck, and laryngeal cancer. Photodynamic therapy is gaining popularity as an effective method of cancer treatment. The growing demand for this treatment encourages manufacturers to develop more advanced and improved versions of their products. Hence, the early detection of cancer is expected to drive market growth during the forecast period. -Here is an Exclusive report talking about Market scenarios with a historical period (2017-2021) and a forecast period (2023-2027). Download Sample Report in minutes!

The report on the photodynamic therapy market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as company analysis. 

The photodynamic therapy market covers the following areas:

• Photodynamic Therapy Market Sizing
• Photodynamic Therapy Market Forecast
• Photodynamic Therapy Market Analysis

Photodynamic Therapy Market 2023-2027 - Market Dynamics

Major Trends

An increase in R&D and advances in technology is a major trend in the market. Market players invest more in R&D to create innovative cancer treatments, including photodynamic therapy. Advanced technologies in the post-genomic era enable non-invasive detection of cancer cells, improving early prediction and treatment. These technologies quantify specific DNA or RNA sequences and proteins, reducing the need for invasive and costly surgeries. Therefore, these factors are expected to drive market growth during the forecast period.

Significant Challenges

The high cost of treatment is a significant challenge restricting market growth. Cancer treatments have become more expensive due to the complex and advanced procedures involved in developing monoclonal antibodies. This has led to increased financial burdens on patients and higher overall treatment costs. The sophisticated manufacturing process raises the production cost, which is reflected in the high sales price of these treatments. Companies invest significant resources in producing monoclonal antibodies, contributing to their high costs. Hence, the high cost is expected to drive market growth during the forecast period.

Drivers, Trends, and challenges have an impact on market dynamics, which can impact businesses. Find more insights in a sample report!

Photodynamic Therapy Market 2023-2027: Market Segmentation

The market is segmented by application (cancer, actinic keratosis, psoriasis, acne, and others), product (photosensitizer drugs, and photodynamic therapy devices), and geography (North America, Europe, Asia, and the Rest of the World (ROW)).

• The market share growth by the cancer segment will be significant during the forecast period. Various factors such as age, lifestyle habits, family history, or inherited conditions, along with prolonged chronic diseases, can increase the risk of developing cancer. Globally, photodynamic therapy is a widely used treatment for cancer. This therapy utilizes a drug activated by a light agent, known as a photosensitizer, to target and kill cancer cells. Hence, these factors are expected to drive segment growth in the market during the forecast period.
• North America is estimated to contribute 36% to the growth of the global market during the forecast period. The photodynamic therapy market is experiencing growth in the region due to the rising incidence of skin diseases and cancer. In addition, factors such as increased awareness about the benefits of photodynamic therapy, the growing adoption of face photodynamic therapy, and the use of photodynamic therapy for acne treatment also contribute to this growth. Therefore, these factors are expected to drive market growth in the region during the forecast period.

This report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters- View Sample Report

Why Buy?

• Add credibility to the strategy.
• Analyzes competitor's offerings. 
• Get a holistic view of the market.
• Grow your profit margin with Technavio- Buy the Report

Companies Mentioned

• Bausch Health Co. Inc.
• Biofrontera AG
• BIOLASE Inc.
• biolitec AG
• Galderma SA
• II VI Inc.
• IRIDEX Corp.
• Lotus Global Group Inc.
• LUMIBIRD SA
• Lutronic Inc
• Modulight Inc.
• Photocure ASA
• Pinnacle Biologics Inc.
• Quanta Systems Spa
• Soligenix Inc.
• SpectraCure AB
• Sun Pharmaceutical Industries Ltd.
• SUS Advancing Technology Co. Ltd.
• Theralase Technologies Inc.
• Eufoton srl

Company Offering

• Bausch Health Co. Inc.- The company offers photodynamic therapy through its subsidiary Bausch and Lomb.
• Biofrontera AG - The company offers a photodynamic therapy device namely BF-RhodoLED.
• LUMIBIRD SA - The company offers photodynamic therapy devices through its subsidiary Omnilux Medical.

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports

The Duchenne muscular dystrophy (DMD) therapeutics market is estimated to grow by USD 2,397.67 million at a CAGR of 21.2% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by type (biologics and small molecules), distribution channel (offline and online), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The high unmet need among patients with Duchenne muscular dystrophy (DMD) is a key factor driving market growth during the forecast period.

The hereditary angioedema (HAE) therapeutics market is estimated to grow by USD 1,647.38 million at a CAGR of 8.95% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by end-user (hospital pharmacies, retail pharmacies, and e-commerce), product (C1-esterase inhibitor, bradykinin B2 receptor antagonist, kallikrein inhibitor, and others), geography (North America, Europe, Asia, and the Rest of the World (ROW)). The growing demand for personalized medicine is a major trend in the market.

Table of Contents

1 Executive Summary

• 1.1 Market Overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of companies included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global photodynamic therapy market 2017 - 2021 
• Exhibit 18: Historic Market Size – Data Table on global photodynamic therapy market 2017 - 2021 ($ million)

• 4.2 Application Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ million)

• 4.3 Product Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – Product Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

• 6.1 Market segments
• Exhibit 30: Chart on Application - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Application - Market share 2022-2027 (%)

• 6.2 Comparison by Application 
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application

• 6.3 Cancer - Market size and forecast 2022-2027 
• Exhibit 34: Chart on Cancer - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Cancer - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Cancer - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Cancer - Year-over-year growth 2022-2027 (%)

• 6.4 Actinic keratosis - Market size and forecast 2022-2027 
• Exhibit 38: Chart on Actinic keratosis - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Actinic keratosis - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Actinic keratosis - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Actinic keratosis - Year-over-year growth 2022-2027 (%)

• 6.5 Psoriasis - Market size and forecast 2022-2027 
• Exhibit 42: Chart on Psoriasis - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Psoriasis - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Psoriasis - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Psoriasis - Year-over-year growth 2022-2027 (%)

• 6.6 Acne - Market size and forecast 2022-2027 
• Exhibit 46: Chart on Acne - Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on Acne - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on Acne - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Acne - Year-over-year growth 2022-2027 (%)

• 6.7 Others - Market size and forecast 2022-2027 
• Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)

• 6.8 Market opportunity by Application 
• Exhibit 54: Market opportunity by Application ($ million)
• Exhibit 55: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Product

• 7.1 Market segments
• Exhibit 56: Chart on Product - Market share 2022-2027 (%)
• Exhibit 57: Data Table on Product - Market share 2022-2027 (%)

• 7.2 Comparison by Product 
• Exhibit 58: Chart on Comparison by Product
• Exhibit 59: Data Table on Comparison by Product

• 7.3 Photosensitizer drugs - Market size and forecast 2022-2027 
• Exhibit 60: Chart on Photosensitizer drugs - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Photosensitizer drugs - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Photosensitizer drugs - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Photosensitizer drugs - Year-over-year growth 2022-2027 (%)

• 7.4 hotodynamic therapy devices - Market size and forecast 2022-2027 
• Exhibit 64: Chart on hotodynamic therapy devices - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Data Table on hotodynamic therapy devices - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Chart on hotodynamic therapy devices - Year-over-year growth 2022-2027 (%)
• Exhibit 67: Data Table on hotodynamic therapy devices - Year-over-year growth 2022-2027 (%)

• 7.5 Market opportunity by Product 
• Exhibit 68: Market opportunity by Product ($ million)
• Exhibit 69: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 71: Chart on Market share by geography 2022-2027 (%)
• Exhibit 72: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 73: Chart on Geographic comparison
• Exhibit 74: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027 
• Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027 
• Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027 
• Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027 
• Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 UK - Market size and forecast 2022-2027 
• Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.9 Germany - Market size and forecast 2022-2027 
• Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.10 China - Market size and forecast 2022-2027 
• Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.11 France - Market size and forecast 2022-2027 
• Exhibit 107: Chart on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 108: Data Table on France - Market size and forecast 2022-2027 ($ million)
• Exhibit 109: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 110: Data Table on France - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 111: Market opportunity by geography ($ million)
• Exhibit 112: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 113: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Company landscape

• 11.1 Overview

• 11.2 Company landscape 
• Exhibit 114: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
• Exhibit 115: Overview on factors of disruption

• 11.4 Industry risks
• Exhibit 116: Impact of key risks on business

12 Company Analysis

• 12.1 Companies covered
• Exhibit 117: Companies covered

• 12.2 Market positioning of companies
• Exhibit 118: Matrix on company position and classification

• 12.3 Bausch Health Co. Inc. 
• Exhibit 119: Bausch Health Co. Inc. - Overview
• Exhibit 120: Bausch Health Co. Inc. - Business segments
• Exhibit 121: Bausch Health Co. Inc. - Key news
• Exhibit 122: Bausch Health Co. Inc. - Key offerings
• Exhibit 123: Bausch Health Co. Inc. - Segment focus

• 12.4 Biofrontera AG
• Exhibit 124: Biofrontera AG - Overview
• Exhibit 125: Biofrontera AG - Product / Service
• Exhibit 126: Biofrontera AG - Key offerings

• 12.5 BIOLASE Inc.
• Exhibit 127: BIOLASE Inc. - Overview
• Exhibit 128: BIOLASE Inc. - Product / Service
• Exhibit 129: BIOLASE Inc. - Key offerings

• 12.6 biolitec AG
• Exhibit 130: biolitec AG - Overview
• Exhibit 131: biolitec AG - Product / Service
• Exhibit 132: biolitec AG - Key offerings

• 12.7 Galderma SA
• Exhibit 133: Galderma SA - Overview
• Exhibit 134: Galderma SA - Product / Service
• Exhibit 135: Galderma SA - Key news
• Exhibit 136: Galderma SA - Key offerings

• 12.8 II VI Inc.
• Exhibit 137: II VI Inc. - Overview
• Exhibit 138: II VI Inc. - Business segments
• Exhibit 139: II VI Inc. - Key news
• Exhibit 140: II VI Inc. - Key offerings
• Exhibit 141: II VI Inc. - Segment focus

• 12.9 IRIDEX Corp.
• Exhibit 142: IRIDEX Corp. - Overview
• Exhibit 143: IRIDEX Corp. - Product / Service
• Exhibit 144: IRIDEX Corp. - Key offerings

• 12.10 Lotus Global Group Inc. 
• Exhibit 145: Lotus Global Group Inc. - Overview
• Exhibit 146: Lotus Global Group Inc. - Product / Service
• Exhibit 147: Lotus Global Group Inc. - Key offerings

• 12.11 LUMIBIRD SA
• Exhibit 148: LUMIBIRD SA - Overview
• Exhibit 149: LUMIBIRD SA - Product / Service
• Exhibit 150: LUMIBIRD SA - Key offerings

• 12.12 Lutronic Inc
• Exhibit 151: Lutronic Inc - Overview
• Exhibit 152: Lutronic Inc - Product / Service
• Exhibit 153: Lutronic Inc - Key offerings

• 12.13 Modulight Inc.
• Exhibit 154: Modulight Inc. - Overview
• Exhibit 155: Modulight Inc. - Product / Service
• Exhibit 156: Modulight Inc. - Key offerings

• 12.14 Soligenix Inc.
• Exhibit 157: Soligenix Inc. - Overview
• Exhibit 158: Soligenix Inc. - Business segments
• Exhibit 159: Soligenix Inc. - Key offerings
• Exhibit 160: Soligenix Inc. - Segment focus

• 12.15 Sun Pharmaceutical Industries Ltd. 
• Exhibit 161: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibit 162: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibit 163: Sun Pharmaceutical Industries Ltd. - Key offerings

• 12.16 SUS Advancing Technology Co. Ltd. 
• Exhibit 164: SUS Advancing Technology Co. Ltd. - Overview
• Exhibit 165: SUS Advancing Technology Co. Ltd. - Product / Service
• Exhibit 166: SUS Advancing Technology Co. Ltd. - Key offerings

• 12.17 Theralase Technologies Inc. 
• Exhibit 167: Theralase Technologies Inc. - Overview
• Exhibit 168: Theralase Technologies Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 169: Inclusions checklist
• Exhibit 170: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 171: Currency conversion rates for US$

• 13.4 Research methodology
• Exhibit 172: Research methodology
• Exhibit 173: Validation techniques employed for market sizing
• Exhibit 174: Information sources

• 13.5 List of abbreviations
• Exhibit 175: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio